The safety and efficacy of granulocyte-macrophage colony-stimulating factor (Sargramostim) added to indinavir- or ritonavir-based antiretroviral therapy: a randomized double-blind, placebo-controlled trial.
暂无分享,去创建一个
J. Bilello | G. Drusano | K. Melbourne | J. Whitmore | D. Stein | G. Skowron | M. Gilbert | J. Agosti | D. Mikolich | A. Mongillo | K. Rana